We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · November 26, 2020

Universal Genetic Testing vs Guideline-Directed Targeted Testing for Hereditary Cancer Syndrome

JAMA Oncology

 

Additional Info

JAMA Oncology
Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome
JAMA Oncol 2020 Oct 30;[EPub Ahead of Print], NJ Samadder, D Riegert-Johnson, L Boardman, D Rhodes, M Wick, S Okuno, KL Kunze, M Golafshar, PLS Uson, L Mountjoy, N Ertz-Archambault, N Patel, EA Rodriguez, B Lizaola-Mayo, M Lehrer, CS Thorpe, NY Yu, ED Esplin, RL Nussbaum, RR Sharp, C Azevedo, M Klint, M Hager, S Macklin-Mantia, AH Bryce, TS Bekaii-Saab, A Sekulic, KA Stewart

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading